Commentary on Almassalha et al., "the greater genomic landscape

The heterogeneous evolution of cancer

Henry T. Lynch, Marc Rendell, Trudy G. Shaw, Peter T. Silberstein, Binh T. Ngo

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

In this issue of Cancer Research, Almassalha and colleagues have proposed a new concept of the development of malignancy, that of the greater genomic landscape. They propose a stressor related exploration of intracellular genomic sites as a response mechanism. This process can express sites with beneficial or deleterious effects, among them those that promote cell proliferation. They point out that their conception is broader, although certainly inclusive, of the process of gene induction. The authors view the physical process of chromatin reorganization as central to the exploration of the genomic landscape. Accordingly, they advocate the development of agents to limit chromatin structural modification as a chemotherapeutic approach in cancer. We found their theory relevant to understand the phenotypic heterogeneity of malignancy, particularly in familial cancer syndromes. For example, the familial atypical multiple mole melanoma (FAMMM) syndrome, related to a gene mutation, is characterized by a diversity of melanocytic lesions, only some of which become malignant melanoma. This new conceptualization can do much to increase understanding of the diversity of malignancy in families with hereditary cancer.

Original languageEnglish (US)
Pages (from-to)5602-5604
Number of pages3
JournalCancer Research
Volume76
Issue number19
DOIs
StatePublished - Oct 1 2016

Fingerprint

Neoplasms
Chromatin
Dysplastic Nevus Syndrome
Physical Phenomena
Genes
Melanoma
Cell Proliferation
Mutation
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Commentary on Almassalha et al., "the greater genomic landscape : The heterogeneous evolution of cancer. / Lynch, Henry T.; Rendell, Marc; Shaw, Trudy G.; Silberstein, Peter T.; Ngo, Binh T.

In: Cancer Research, Vol. 76, No. 19, 01.10.2016, p. 5602-5604.

Research output: Contribution to journalReview article

@article{95f001335d3c4afe99b4f8bf8a7fc782,
title = "Commentary on Almassalha et al., {"}the greater genomic landscape: The heterogeneous evolution of cancer",
abstract = "In this issue of Cancer Research, Almassalha and colleagues have proposed a new concept of the development of malignancy, that of the greater genomic landscape. They propose a stressor related exploration of intracellular genomic sites as a response mechanism. This process can express sites with beneficial or deleterious effects, among them those that promote cell proliferation. They point out that their conception is broader, although certainly inclusive, of the process of gene induction. The authors view the physical process of chromatin reorganization as central to the exploration of the genomic landscape. Accordingly, they advocate the development of agents to limit chromatin structural modification as a chemotherapeutic approach in cancer. We found their theory relevant to understand the phenotypic heterogeneity of malignancy, particularly in familial cancer syndromes. For example, the familial atypical multiple mole melanoma (FAMMM) syndrome, related to a gene mutation, is characterized by a diversity of melanocytic lesions, only some of which become malignant melanoma. This new conceptualization can do much to increase understanding of the diversity of malignancy in families with hereditary cancer.",
author = "Lynch, {Henry T.} and Marc Rendell and Shaw, {Trudy G.} and Silberstein, {Peter T.} and Ngo, {Binh T.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1158/0008-5472.CAN-16-2319",
language = "English (US)",
volume = "76",
pages = "5602--5604",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Commentary on Almassalha et al., "the greater genomic landscape

T2 - The heterogeneous evolution of cancer

AU - Lynch, Henry T.

AU - Rendell, Marc

AU - Shaw, Trudy G.

AU - Silberstein, Peter T.

AU - Ngo, Binh T.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - In this issue of Cancer Research, Almassalha and colleagues have proposed a new concept of the development of malignancy, that of the greater genomic landscape. They propose a stressor related exploration of intracellular genomic sites as a response mechanism. This process can express sites with beneficial or deleterious effects, among them those that promote cell proliferation. They point out that their conception is broader, although certainly inclusive, of the process of gene induction. The authors view the physical process of chromatin reorganization as central to the exploration of the genomic landscape. Accordingly, they advocate the development of agents to limit chromatin structural modification as a chemotherapeutic approach in cancer. We found their theory relevant to understand the phenotypic heterogeneity of malignancy, particularly in familial cancer syndromes. For example, the familial atypical multiple mole melanoma (FAMMM) syndrome, related to a gene mutation, is characterized by a diversity of melanocytic lesions, only some of which become malignant melanoma. This new conceptualization can do much to increase understanding of the diversity of malignancy in families with hereditary cancer.

AB - In this issue of Cancer Research, Almassalha and colleagues have proposed a new concept of the development of malignancy, that of the greater genomic landscape. They propose a stressor related exploration of intracellular genomic sites as a response mechanism. This process can express sites with beneficial or deleterious effects, among them those that promote cell proliferation. They point out that their conception is broader, although certainly inclusive, of the process of gene induction. The authors view the physical process of chromatin reorganization as central to the exploration of the genomic landscape. Accordingly, they advocate the development of agents to limit chromatin structural modification as a chemotherapeutic approach in cancer. We found their theory relevant to understand the phenotypic heterogeneity of malignancy, particularly in familial cancer syndromes. For example, the familial atypical multiple mole melanoma (FAMMM) syndrome, related to a gene mutation, is characterized by a diversity of melanocytic lesions, only some of which become malignant melanoma. This new conceptualization can do much to increase understanding of the diversity of malignancy in families with hereditary cancer.

UR - http://www.scopus.com/inward/record.url?scp=84989902153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989902153&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-16-2319

DO - 10.1158/0008-5472.CAN-16-2319

M3 - Review article

VL - 76

SP - 5602

EP - 5604

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 19

ER -